The COVID-19 pandemic has illuminated an ongoing concern about antimicrobial resistance in dermatology and requires a recommitment from clinicians to follow guidelines that promote good stewardship.
Investigators reviewed patterns of antibiotic consumption in each of the WHO Access, Watch, and Reserve (AWaRe) categories over a span of 15 years and documented changes.
For patients with chronic edema of the leg and cellulitis, compression therapy results in a lower incidence of cellulitis recurrence.
The FDA has expanded the approval of Sivextro.
The likelihood of having a fungal infection was increased in association with cannabis use in 2016.
Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage before and personalizing prophylaxis for carriers after elective colorectal surgery reduces the risk of surgical site infections.
Risk for infection influenced by defect size and use of complex layered closure in closed surgical wounds.
A high prevalence of antibiotic use and skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus were identified in Indigenous Canadian communities.
Patients with SLE have increased colonization with Staphylococcus aureus in cutaneous lupus erythematosus lesions.
Clinical prescribing practices for topical antibiotics after dermatologic procedures do not align with recommendations put forth by the Centers for Disease Control and Prevention.
